You are here: Industry Insights > clinical

News List

Vivera Pharma, Parexel Ink Clinical Services Agreement ContractPharma
December 11, 2019
Parexel to conduct Phase I study to evaluate the bioavailability of TABMELT technology and provide regulatory support for Vivera's IND.
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. En-CPhI.CN
October 12, 2019
Kangpu Biopharmaceuticals announced that it has successfully completed a first-in-human phase I single ascending dose (SAD) clinical study of KPG-818 conducted in the United States.
Schizophrenia Clinical Research Receives NIMH Funding americanpharmaceuticalreview
September 23, 2019
Feinstein Institutes for Medical Research scientists have been awarded a five-year, $7.3 million National Institutes of Mental Health (NIMH) grant to support their research in improved schizophrenia treatment.
PCI Unveils Clinical Center of Excellence contractpharma
September 23, 2019
Expanded clinical services facility in Rockford, IL to support growth and flexibility with 30,000 additional sq. ft.
Cosentyx® (secukinumab) meets clinical trial endpoints europeanpharmaceuticalreview
September 19, 2019
Cosentyx®, a treatment for an inflammatory disease has met its primary endpoints in patients during a Phase III trial.
Lilly's Pain Clinical Trial Protocol Selected for FDA Trial Designs Pilot Meeting Program americanpharmaceuticalreview
September 09, 2019
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) has accepted its application to enter the Complex Innovative Trial Designs (CID) Pilot Meeting Program...
Velesco Pharma Set For Clinical Manufacturing Capacity Expansion contractpharma
September 09, 2019
New Michigan facility to be fully operational by the end of year.
Catalent Invests $9M in New Clinical Supply Facility contractpharma
September 06, 2019
New 24,257 sq.-ft. facility in San Diego will specialize in services for early-phase clinical trials.
Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI americanpharmaceuticalreview
September 03, 2019
Acurx Pharmaceuticals announced its lead product candidate, ACX-362E, has successfully completed the 68-subject, double-blind, placebo-controlled, multiple-ascending dose Phase 1 clinical trial of ACX-362E in healthy volunteers.
Men Should Be Included in Breast Cancer Clinical Trials drugs
August 27, 2019
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page